Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection

Autor: Chen, Jiahe, Gong, Cynthia L., Hitchcock, Matthew M., Holubar, Marisa, Deresinski, Stanley, Hay, Joel W.
Zdroj: In Clinical Microbiology and Infection October 2021 27(10):1448-1454
Databáze: ScienceDirect